Congenital Disorders of Glycosylation
6
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Study of Hemostasis in Patients With Congenital Disorder of Glycosylation
Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism
Role of the Endothelium in Stroke-like Episode Among CDG Patients
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation